The collaborative innovation results of medical industry were unveiled at the CIIE. The Axis C-Sheath electrode lead guide sheath set had its world premiere at the Boston Scientific booth.

Shanghai, November 6, 2026 - During the 9th China International Import Expo, the Axis C-Sheath electrode lead sheath set (hereinafter referred to as "Axis C sheath") celebrated its world premiere at the Boston Scientific booth and was officially launched. The Axis C sheath is designed for physiological pacing procedures such as conduction system pacing, and provides a variety of sheath bending options. It is planned to be used with Boston Scientific related electrode leads after they are approved in the future. The product originates from the actual needs of China's clinical frontline and is jointly created by Boston Scientific and Huanxin Medical Technology (Suzhou) Co., Ltd. (hereinafter referred to as "Huanxin Medical"). It is an epitome of medical and industrial collaboration to promote device innovation.

With the continuous development of cardiac pacing technology, clinical treatment is evolving towards pacing methods that are more consistent with normal physiological conditions. Cardiac conduction system pacing (CSP) achieves a cardiac electrical activation sequence closer to normal physiological conditions by directly stimulating the heart's own conduction system. With the continuous development of related surgical procedures, different pacing sites, anatomical characteristics and implantation routes have put forward more specific requirements for the precise positioning, support performance, operational stability and intraoperative imaging of the device.

The Axis C sheath forms a variety of sheath bends around different physiological pacing scenarios, and is designed specifically in aspects such as support strength and intraoperative imaging to provide more suitable device options for clinical use.

Professor Zhang Shu from Fuwai Hospital of the Chinese Academy of Medical Sciences, chairman of the Cardiac Rhythmology Professional Committee of the Chinese Medical Doctor Association and president of the Arrhythmia Technology Branch of the Chinese Medical Equipment Association, pointed out that China's clinical practice and academic research in the field of conduction system pacing have continued to make progress and are at the world's leading level. The society also continues to promote the standardized application of relevant technologies through academic exchanges, expert consensus and standardized training. The launch of Axis C sheath reflects the localization of innovation and the active exploration of special device innovation guided by China's clinical needs and through medical-industrial collaboration.

Chairman-elect of the Chinese Medical Association's Cardiac Electrophysiology and Pacing Branch, Professor Tang Baopeng of the First Affiliated Hospital of Xinjiang Medical University, Vice Chairman of the Chinese Medical Association's Cardiac Electrophysiology and Pacing Branch, Professor Su Yangang of Zhongshan Hospital Affiliated to Fudan University, Vice Chairman of the Cardiac Rhythm Professional Committee of the Chinese Medical Doctor Association, Nanjing University School of Medicine Professor Xu Wei from the Gulou Hospital affiliated to the hospital, Professor Li Ruogu, elected chairman of the Shanghai Heart Rhythm Society and director of the Department of Cardiology, Shanghai Chest Hospital, and Professor Chen Xueying, head of the pacing subspecialty of the Department of Cardiology, Zhongshan Hospital, Fudan University, exchanged views on the technological evolution, clinical application value and future development direction of physiological pacing.

From the perspective of clinical practice, Professor Chen Xueying from Zhongshan Hospital Affiliated to Fudan University said: "The key to a good sheath is to truly fit the clinical usage habits. Different physiological pacing procedures have different requirements for sheath bending, support strength and intraoperative imaging. The launch of the Axis C sheath reflects attention to clinical needs and also provides new support for the standardized application of related procedures."

Zhu Zhouli, Vice President of Boston Scientific China's Cardiac Rhythm Management and Neuromodulation Division and IAS China Innovation Training Academy, said: "Boston Scientific has been deeply involved in the field of cardiac rhythm management for many years. It is not just about launching products, but also being professional-oriented and long-term clinical accompaniment - understanding every step of the evolution of procedures. Axis The C-sheath was born out of such long-term collaboration: it originated from the real operational needs of Chinese doctors in physiological pacing practice, allowing clinical experience to enter product design and verification earlier. In the future, we will continue to work with clinical experts to promote the development of pacing and even the entire cardiac rhythm management discipline. "

From demand insight to clinical application, a medical device needs to go through multiple links such as product definition, R&D and design, engineering development, manufacturing, quality verification and commercialization. Only by allowing each link to be undertaken by the most competent party can innovation reach the clinic more efficiently.

Cao Gangyi, founder and general manager of Huanxin Medical, said: "In this cooperation, Huanxin Medical takes advantage of the cost and efficiency of local manufacturing and works closely with Boston Scientific to promote the implementation of innovative designs into actual products. We look forward to this kind of cooperation to help more clinical pain points to be implemented into real devices that serve the front line."

Xiulan Wu, Vice President of Boston Scientific Global Supply Chain China, said: "China has rich clinical practices, a complete industrial chain, flexible engineering capabilities and a vibrant innovation ecosystem, where good clinical needs have the opportunity to become good products faster. The cooperation with Axis C Sheath combines the response speed and manufacturing capabilities of the local supply chain with Boston Scientific's global quality management experience and product verification standards to improve efficiency while ensuring that product quality is consistent with global standards."

The development of medical technology has always been closely linked to real clinical demands. A technological breakthrough may start from a doctor's long-term thinking about a certain treatment problem, or it may originate from a subtle insight into the design of a device during an operation. The practice of Axis C sheath also proves that China is not only an important market for global medical innovation, but also becoming an increasingly important source of innovation. In the future, Boston Scientific hopes to join hands with more Chinese clinical experts and local innovation partners to enable more innovations derived from China’s clinical needs and embodying Chinese wisdom to be implemented in China and benefit more patients.